The ASPIRE Award program is particularly interested in innovative ideas in the field of primary and secondary immunodeficiencies and the role of immunoglobulin therapy.

Proposals aimed to provide novel insights into the diagnosis, clinical course, or treatment with immunoglobulins are invited to enter.

The ASPIRE Award program offers 1 award of Eur 50,000 to applicants whose proposals best match the program's objectives as assessed by an independent review committee.

The ASPIRE award aims to:

• Improve immunodeficiency diseases awareness, diagnosis and management
• Develop novel concepts in immunoglobulin therapy research